松质骨内注射富血小板血浆治疗中晚期膝关节骨性关节炎的临床效果

doi:10.20047/j.issn1673-7210.2023.03.18

摘要
图/表
参考文献(27)
相关文章 (15)

全文: PDF (754 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探索膝关节松质骨及关节腔注射富血小板血浆治疗中晚期膝关节骨性关节炎的临床效果。方法选取2019年1月至2020年12月首都医科大学附属北京康复医院和山东大学齐鲁医院德州医院收治膝关节骨性关节炎患者72例，根据随机数字表法将其分为两组，各36例。关节腔注射组进行富血小板血浆关节腔内注射，关节腔+松质骨注射组进行富血小板血浆关节腔联合松质骨注射。比较两组治疗前，治疗后第1个月、3个月、6个月、12个月膝关节视觉模拟评分法（VAS）评分、美国西大略和麦克马斯特大学骨关节炎指数评分（WOMAC）。结果两组治疗后第3、6、12个月时VAS和WOMAC评分均低于治疗前，差异有统计学意义（P＜0.05）。治疗后第1个月时关节腔+松质骨注射组WOMAC评分低于关节腔注射组，差异有统计学意义（P＜0.05）。治疗后第3、6、12个月时关节腔+松质骨注射组VAS和WOMAC评分均低于关节腔注射组，差异有统计学意义（P＜0.05)。结论关节腔联合松质骨注射富血小板血浆能够有效减轻中晚期膝关节骨性关节炎患者疼痛，改善膝关节功能，有望在临床上推广使用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	郭峰1 宋兵2 解焕鑫1 章耀华1 刘晓磊1 张鸿悦1 杨华清1▲

关键词 ：富血小板血浆, 骨性关节炎, 关节腔穿刺, 松质骨穿刺

Abstract：Objective To explore and analyze the clinical effect of injecting platelet-rich plasma into subchondral cancellous bone and articular cavity for advanced knee osteoarthritis. Methods A total of 72 patients with knee osteoarthritis admitted to Beijing Rehabilitation Hospital Affiliated to Capital Medical University and Dezhou Hospital of Qilu Hospital of Shandong University from January 2019 to December 2020 were selected and they were divided into two groups according to random number table method, with 36 cases in each group. The articular injection group received intra articular injection of platelet-rich plasma and the articular + cancellous bone injection group received intra articular injection of plaletet plasmas combined with cancellous bone injection. Visual analogue scale (VAS) scores, Western Ontario and McMaster University osteoarthritis index scores (WOMAC) were compared between the two groups before treatment and one, three, six, and twelve months after treatment. Results VAS and WOMAC scores at three, six and twelve months after treatment in the two group were lower than before treatment, and the differences were statistically significant (P＜0.05). One month after treatment, the WOMAC score of the articular + cancellous bone injection group was lower than that of the articular injection group, and the difference was statistically significant (P＜0.05). At three, six and twelve months after treatment, VAS and WOMAC scores in the articular + cancellous bone injection group were lower than those in the articular injection group, with statistical significances (P＜0.05). Conclusion PRP combined with cancellous bone injection can effectively delay the development of severe knee osteoarthritis, reduce pain and improve knee function without serious side effects. It is expected to be widely used in clinical practice, but further clinical trials are needed.

Key words： Platelet-rich plasma Osteoarthritis Joint ventral puncture Cancellous bone puncture

基金资助:北京市首都卫生发展科研专项项目（2022-2- 2253）；
首都医科大学附属北京康复医院科研发展专项项目（2021-014）。

作者简介: 郭峰（1978.6-），男，医学硕士，副主任医师；研究方向：运动功能康复。

引用本文:

郭峰1 宋兵2 解焕鑫1 章耀华1 刘晓磊1 张鸿悦1 杨华清1▲. 松质骨内注射富血小板血浆治疗中晚期膝关节骨性关节炎的临床效果[J]. 中国医药导报, 2023, 20(3): 79-83.
GUO Feng1 SONG Bing2 XIE Huanxin1 ZHANG Yaohua1 LIU Xiaolei3 ZHANG Hongyue1 YANG Huaqing1. Clinical effect of intraspecular injection of platelet-rich plasma in the treatment of advanced knee osteoarthritis. 中国医药导报, 2023, 20(3): 79-83.

链接本文:

https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.03.18 或 https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I3/79

[1] 樊子娟，王桂杉，李川，等.《中国骨关节炎诊疗指南（2021年版）》解读和评价[J].中国循证医学杂志，2022， 22（6）：621-627.
[2] Cook CS，Smith PA. Clinical Update：Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee [J]. Curr Rev Musculoskelet Med，2018，11（4）：583-592.
[3] Dhillon MS，Patel S，Bansal T. Improvising PRP for use in osteoarthritis knee- upcoming trends and futuristic view [J]. J Clin Orthop Trauma，2019，10（1）：32-35.
[4] O’Connell B，Wragg NM，Wilson SL. The use of PRP injections in the management of knee osteoarthritis [J]. Cell Tissue Res，2019，376（2）：143-152.
[5] Chouhan DK，Dhillon MS，Patel S，et al. Multiple Platelet- Rich Plasma Injections Versus Single Platelet-Rich Plasma Injection in Early Osteoarthritis of the Knee：An Experimental Study in a Guinea Pig Model of Early Knee Osteoarthritis [J]. Am J Sports Med，2019，47（10）：2300-2307.
[6] Bennell KL，Hunter DJ，Paterson KL. Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis [J]. Curr Rheumatol Rep，2017，19（5）：24.
[7] Vilchez-Cavazos F，Millán-Alanís JM，Blázquez-Saldaña J，et al. Comparison of the Clinical Effectiveness of Single Versus Multiple Injections of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis：A Systematic Review and Meta-analysis [J]. Orthop J Sports Med，2019，7（12）：23259 67119887116.
[8] Charlier E，Deroyer C，Ciregia F，et al. Chondrocyte dedifferentiation and osteoarthritis （OA）[J]. Biochem Pharmacol，2019，（165）：49-65.
[9] Huang Z，Kraus VB. Does lipopolysaccharide-mediated inflammation have a role in OA? [J]. Nat Rev Rheumatol，2016， 12（2）：123-129.
[10] O’Neill TW，Felson DT. Mechanisms of Osteoarthritis （OA） Pain [J]. Curr Osteoporos Rep，2018，16（5）：611-616.
[11] Co■kun HS，Yurtbay A，Say F. Platelet Rich Plasma Versus Autologous Conditioned Serum in Osteoarthritis of the Knee：Clinical Results of a Five-Year Retrospective Study [J]. Cureus，2022，14（4）：e24500.
[12] 康志宏.阶梯综合疗法在膝关节骨性关节炎患者中的应用效果[J].中国医药指南，2021，19（27）：43-45.
[13] 张二瑞，黄遂柱.膝关节骨性关节炎诊断及治疗的研究[J].医学信息，2021，34（12）：58-60.
[14] Dai WL，Zhou AG，Zhang H，et al. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis：A Meta- analysis of Randomized Controlled Trials[J]. Arthroscopy，2017，33（3）：659-670.
[15] 王养发，刘军，潘建科，等.富血小板血浆与透明质酸治疗膝骨关节炎疗效对比的Meta分析[J].中国组织工程研究，2020，24（27）：4421-4428.
[16] Delanois RE，Sax OC，Chen Z，et al. Biologic Therapies for the Treatment of Knee Osteoarthritis：An Updated Systematic Review [J]. J Arthroplasty，2022.21：S0883-5403.
[17] Li M，Han H，Chen L，et al. Platelet-rich plasma contributes to chondroprotection by repairing mitochondrial function via AMPK/NF-κB signaling in osteoarthritic chondrocytes[J]. Tissue Cell，2022，77：101830.
[18] O’Donnell C，Migliore E，Grandi FC，et al. Platelet-Rich Plasma （PRP） From Older Males With Knee Osteoarthritis Depresses Chondrocyte Metabolism and Upregulates Inflammation [J]. J Orthop Res，2019，37（8）：1760-1770.
[19] 胥韵，沃春新，罗昌菊.富血小板血浆治疗膝关节骨性关节炎的临床疗效及影响因素分析[J].中国骨与关节损伤杂志，2022，37（2）：197-200.
[20] 李志达，彭小梅.富血小板血浆对膝关节骨性关节炎患者关节功能及疼痛程度的影响[J].临床医学工程，2020， 27（7）：909-910.
[21] Sánchez M，Fiz N，Guadilla J，et al. Intraosseous infiltration of platelet-rich plasma for severe knee osteoarthritis [J]. Arthrosc Tech，2014，3（6）：e713-e717.
[22] 苏柯，白玉明，王军，等.关节内联合松质骨内注射富血小板血浆治疗膝骨关节炎的临床观察[J].中华关节外科杂志（电子版），2017，11（5）：471-476.
[23] 侯增涛,朱金强,董志伟,等.富血小板血浆关节腔注射治疗膝关节骨性关节炎的临床效果[J].中国当代医药，2022，29（27）：67-69，73.
[24] 张莲,侯费祎,李慎松,等.关节镜清理术联合富血小板血浆注射治疗早中期膝骨关节炎的临床效果评价[J].中国医药，2022，17（10）：1524-1528.
[25] Lewis E，Merghani K，Robertson I，et al. The effectiveness of leucocyte-poor platelet-rich plasma injections on symptomatic early osteoarthritis of the knee：the PEAK randomized controlled trial [J]. Bone Joint J，2022，104-B（6）：663-671.
[26] Szwedowski D，Mobasheri A，Moniuszko A，et al. Intra-Articular Injection of Platelet-Rich Plasma Is More Effective than Hyaluronic Acid or Steroid Injection in the Treatment of Mild to Moderate Knee Osteoarthritis：A Prospective，Randomized，Triple-Parallel Clinical Trial [J]. Biomedicines，2022，10（5）：991.
[27] Zhang Z，Schon L. The Current Status of Clinical Trials on Biologics for Cartilage Repair and Osteoarthritis Treatment：An Analysis of ClinicalTrials.gov Data [J]. Cartilage，2022，13（2）：788759863.